๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sequential therapy in renal cell carcinoma

โœ Scribed by Bernard Escudier; Marine Gross Goupil; Christophe Massard; Karim Fizazi

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
117 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

CCNU, vinblastine, and delalutin therapy
CCNU, vinblastine, and delalutin therapy in renal cell carcinoma
โœ Vosika, Gerald J. ;Ryan, Michael J. ;Fortuny, Ignacio A. ;Meyer, Cynthia ;Kiang, ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 189 KB

## Abstract Advanced renal cell carcinoma is relatively resistant to most adequately evaluated chemotherapeutic agents. The combination of CCNU and vinblastine, which has antitumor activity in a frog renal carcinoma model system, has demonstrated activity in initial studies in man. The current stud

Telomerase activity in renal cell carcin
Telomerase activity in renal cell carcinoma
โœ Ken-ichiro Yoshida; Shu-ichi Sakamoto; Shuhei Sumi; Yotsuo Higashi; Satoshi Kita ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB ๐Ÿ‘ 2 views

## BACKGROUND. Telomerase activity has been shown to be increased in numerous tumors and cell lines, although to the authors' knowledge there has been no previous assessment of telomerase activity in renal cell carcinoma (RCC). To examine whether telomerase activity could be used as a biochemical p

Targeting mTOR in renal cell carcinoma
Targeting mTOR in renal cell carcinoma
โœ Gary R. Hudes ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 1 views